Search research articles
Contact Us
Filters
Showing results (71-80 of 98) with videos related to
Page
of 10
Sort By:
Praxis
|
May 28, 2025
Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate Cancer
Arnoud J Templeton, Vérane Achard, Dilara Akhoundova, et al.
Swiss Medical Weekly
|
August 20, 2023
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer
Arnoud J Templeton, Aurelius Omlin, Dominik Berthold, et al.
JCO Precision Oncology
|
August 7, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations
Mihaela Aldea, Emeline Orillard, Alice Bernard-Tessier, et al.
European Urology Oncology
|
May 18, 2019
Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer
Semini Sumanasuriya, Aurelius Omlin, Andrew Armstrong, et al.
European Urology
|
December 3, 2014
PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate
Roberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, et al.
The Lancet. Oncology
|
July 2, 2013
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
Shahneen K Sandhu, William R Schelman, George Wilding, et al.
British Journal of Cancer
|
September 18, 2015
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
Elizabeth A Punnoose, Roberta Ferraldeschi, Edith Szafer-Glusman, et al.
European Urology Open Science
|
September 23, 2024
First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)
Stefanie Fischer, Silke Gillessen, Odile Stalder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2019
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
Emmanuel S Antonarakis, Josep M Piulats, Marine Gross-Goupil, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
Ursula M Vogl, Tomasz M Beer, Ian D Davis, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 98) with videos related to
Sort By:
Page
of 10
Praxis
|
May 28, 2025
Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate Cancer
Arnoud J Templeton, Vérane Achard, Dilara Akhoundova, et al.
Swiss Medical Weekly
|
August 20, 2023
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer
Arnoud J Templeton, Aurelius Omlin, Dominik Berthold, et al.
JCO Precision Oncology
|
August 7, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations
Mihaela Aldea, Emeline Orillard, Alice Bernard-Tessier, et al.
European Urology Oncology
|
May 18, 2019
Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer
Semini Sumanasuriya, Aurelius Omlin, Andrew Armstrong, et al.
European Urology
|
December 3, 2014
PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate
Roberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, et al.
The Lancet. Oncology
|
July 2, 2013
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial
Shahneen K Sandhu, William R Schelman, George Wilding, et al.
British Journal of Cancer
|
September 18, 2015
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
Elizabeth A Punnoose, Roberta Ferraldeschi, Edith Szafer-Glusman, et al.
European Urology Open Science
|
September 23, 2024
First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)
Stefanie Fischer, Silke Gillessen, Odile Stalder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2019
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
Emmanuel S Antonarakis, Josep M Piulats, Marine Gross-Goupil, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings
Ursula M Vogl, Tomasz M Beer, Ian D Davis, et al.
Page
of 10